Production (Stage)
Mustang Bio, Inc.
MBIO
$1.24
-$0.01-0.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.93M | 4.14M | 6.54M | 7.27M | 8.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.58M | 12.55M | 21.44M | 31.64M | 39.64M |
| Operating Income | -7.58M | -12.55M | -21.44M | -31.64M | -39.64M |
| Income Before Tax | -10.71M | -15.75M | -23.42M | -32.06M | -40.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.71 | -15.75 | -23.42 | -32.06 | -40.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.71M | -15.75M | -23.42M | -32.06M | -40.10M |
| EBIT | -7.58M | -12.55M | -21.44M | -31.64M | -39.64M |
| EBITDA | -7.16M | -11.88M | -20.53M | -30.50M | -38.24M |
| EPS Basic | -20.64 | -45.40 | -87.48 | -147.11 | -229.26 |
| Normalized Basic EPS | -8.67 | -24.15 | -52.08 | -94.51 | -149.44 |
| EPS Diluted | -20.64 | -45.40 | -87.48 | -147.11 | -229.26 |
| Normalized Diluted EPS | -8.67 | -24.15 | -52.08 | -94.51 | -149.44 |
| Average Basic Shares Outstanding | 5.07M | 2.42M | 1.61M | 1.04M | 735.40K |
| Average Diluted Shares Outstanding | 5.07M | 2.42M | 1.61M | 1.04M | 735.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |